1	4	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Discussion	_	_	NN	_	_	_	_	_


1	Here	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	describe	_	_	VBP	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	link	_	_	NN	_	_	_	_	_
7	between	_	_	IN	_	_	_	_	_
8	fructose	_	_	NN	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	NO	_	_	DT	_	_	_	_	_
11	levels	_	_	NNS	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	NTS	_	_	NNP	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	as	_	_	RB	_	_	_	_	_
17	well	_	_	RB	_	_	_	_	_
18	as	_	_	IN	_	_	_	_	_
19	its	_	_	PRP$	_	_	_	_	_
20	association	_	_	NN	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	baroreflex	_	_	NN	_	_	_	_	_
23	sensitivity	_	_	NN	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	activation	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	CNS	_	_	NNP	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Our	_	_	PRP$	_	_	_	_	_
2	findings	_	_	NNS	_	_	_	_	_
3	showed	_	_	VBD	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	excessive	_	_	JJ	_	_	_	_	_
6	fructose	_	_	NN	_	_	_	_	_
7	consumption	_	_	NN	_	_	_	_	_
8	increased	_	_	VBD	_	_	_	_	_
9	BP	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	renal	_	_	JJ	_	_	_	_	_
12	SNA	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	decreased	_	_	VBD	_	_	_	_	_
15	NO	_	_	DT	_	_	_	_	_
16	bioavailability	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	impaired	_	_	VBD	_	_	_	_	_
20	baroreflex	_	_	NN	_	_	_	_	_
21	response	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Excessive	_	_	JJ	_	_	_	_	_
2	fructose	_	_	NN	_	_	_	_	_
3	intake	_	_	NN	_	_	_	_	_
4	increased	_	_	VBN	_	_	_	_	_
5	serum	_	_	NN	_	_	_	_	_
6	triglycerides	_	_	NNS	_	_	_	_	_
7	levels	_	_	NNS	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	induced	_	_	VBN	_	_	_	_	_
10	BP	_	_	NN	_	_	_	_	_
11	elevation	_	_	NN	_	_	_	_	_
12	by	_	_	IN	_	_	_	_	_
13	stimulating	_	_	VBG	_	_	_	_	_
14	SNA	_	_	NN	_	_	_	_	_
15	;	_	_	:	_	_	_	_	_
16	however	_	_	RB	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	alleviation	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	hypertriglyceridemia	_	_	NN	_	_	_	_	_
21	did	_	_	VBD	_	_	_	_	_
22	not	_	_	RB	_	_	_	_	_
23	attenuate	_	_	VB	_	_	_	_	_
24	sympathetic	_	_	JJ	_	_	_	_	_
25	activation	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	only	_	_	RB	_	_	_	_	_
28	slightly	_	_	RB	_	_	_	_	_
29	lowered	_	_	VBN	_	_	_	_	_
30	BP	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	suggested	_	_	VBN	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	mechanistically	_	_	RB	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	SNA	_	_	NNP	_	_	_	_	_
9	played	_	_	VBD	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	role	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	modulating	_	_	VBG	_	_	_	_	_
14	changes	_	_	NNS	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	BP	_	_	NNP	_	_	_	_	_
17	due	_	_	JJ	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	increased	_	_	VBN	_	_	_	_	_
20	fructose	_	_	NN	_	_	_	_	_
21	consumption	_	_	NN	_	_	_	_	_
22	through	_	_	IN	_	_	_	_	_
23	another	_	_	DT	_	_	_	_	_
24	unknown	_	_	JJ	_	_	_	_	_
25	pathway	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Epidemiological	_	_	JJ	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	have	_	_	VBP	_	_	_	_	_
4	hinted	_	_	VBN	_	_	_	_	_
5	at	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	link	_	_	NN	_	_	_	_	_
8	between	_	_	IN	_	_	_	_	_
9	fructose	_	_	NN	_	_	_	_	_
10	consumption	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	elevated	_	_	VBN	_	_	_	_	_
13	blood	_	_	NN	_	_	_	_	_
14	pressure	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_
16	Jalal	_	_	NNP	_	_	_	_	_
17	et	_	_	FW	_	_	_	_	_
18	al.	_	_	FW	_	_	_	_	_
19	reported	_	_	VBD	_	_	_	_	_
20	that	_	_	IN	_	_	_	_	_
21	excess	_	_	JJ	_	_	_	_	_
22	dietary	_	_	NN	_	_	_	_	_
23	fructose	_	_	NN	_	_	_	_	_
24	(	_	_	-LRB-	_	_	_	_	_
25	≥74	_	_	CD	_	_	_	_	_
26	g/day	_	_	NNP	_	_	_	_	_
27	)	_	_	-RRB-	_	_	_	_	_
28	in	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	form	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	added	_	_	VBN	_	_	_	_	_
33	sugar	_	_	NN	_	_	_	_	_
34	was	_	_	VBD	_	_	_	_	_
35	associated	_	_	VBN	_	_	_	_	_
36	with	_	_	IN	_	_	_	_	_
37	higher	_	_	JJR	_	_	_	_	_
38	BP	_	_	NN	_	_	_	_	_
39	values	_	_	NNS	_	_	_	_	_
40	in	_	_	IN	_	_	_	_	_
41	adults	_	_	NNS	_	_	_	_	_
42	in	_	_	IN	_	_	_	_	_
43	the	_	_	DT	_	_	_	_	_
44	United	_	_	NNP	_	_	_	_	_
45	States	_	_	NNPS	_	_	_	_	_
46	who	_	_	WP	_	_	_	_	_
47	did	_	_	VBD	_	_	_	_	_
48	not	_	_	RB	_	_	_	_	_
49	have	_	_	VB	_	_	_	_	_
50	a	_	_	DT	_	_	_	_	_
51	history	_	_	NN	_	_	_	_	_
52	of	_	_	IN	_	_	_	_	_
53	hypertension	_	_	NN	_	_	_	_	_
54	.	_	_	.	_	_	_	_	_


1	Similarly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	study	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	4867	_	_	CD	_	_	_	_	_
7	adolescents	_	_	NNS	_	_	_	_	_
8	found	_	_	VBD	_	_	_	_	_
9	that	_	_	IN	_	_	_	_	_
10	SBP	_	_	NNP	_	_	_	_	_
11	rose	_	_	VBD	_	_	_	_	_
12	by	_	_	IN	_	_	_	_	_
13	2	_	_	CD	_	_	_	_	_
14	mmHg	_	_	NN	_	_	_	_	_
15	following	_	_	VBG	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	intake	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	sugar-sweetened	_	_	JJ	_	_	_	_	_
20	beverages	_	_	NNS	_	_	_	_	_
21	from	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	lowest	_	_	JJS	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	highest	_	_	JJS	_	_	_	_	_
27	category	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	prospective	_	_	JJ	_	_	_	_	_
4	study	_	_	NN	_	_	_	_	_
5	involving	_	_	VBG	_	_	_	_	_
6	adults	_	_	NNS	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	United	_	_	NNP	_	_	_	_	_
10	States	_	_	NNPS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	Chen	_	_	NNP	_	_	_	_	_
13	et	_	_	FW	_	_	_	_	_
14	al.	_	_	FW	_	_	_	_	_
15	found	_	_	VBD	_	_	_	_	_
16	that	_	_	IN	_	_	_	_	_
17	intake	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	one	_	_	CD	_	_	_	_	_
20	less	_	_	RBR	_	_	_	_	_
21	sugar-sweetened	_	_	JJ	_	_	_	_	_
22	beverage	_	_	NN	_	_	_	_	_
23	per	_	_	IN	_	_	_	_	_
24	day	_	_	NN	_	_	_	_	_
25	was	_	_	VBD	_	_	_	_	_
26	associated	_	_	VBN	_	_	_	_	_
27	with	_	_	IN	_	_	_	_	_
28	a	_	_	DT	_	_	_	_	_
29	1.8	_	_	CD	_	_	_	_	_
30	mmHg	_	_	NN	_	_	_	_	_
31	reduction	_	_	NN	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	SBP	_	_	NN	_	_	_	_	_
34	and	_	_	CC	_	_	_	_	_
35	a	_	_	DT	_	_	_	_	_
36	1.1	_	_	CD	_	_	_	_	_
37	mmHg	_	_	NN	_	_	_	_	_
38	reduction	_	_	NN	_	_	_	_	_
39	in	_	_	IN	_	_	_	_	_
40	DBP	_	_	NNP	_	_	_	_	_
41	over	_	_	IN	_	_	_	_	_
42	18	_	_	CD	_	_	_	_	_
43	months	_	_	NNS	_	_	_	_	_
44	.	_	_	.	_	_	_	_	_


1	Some	_	_	DT	_	_	_	_	_
2	animal	_	_	NN	_	_	_	_	_
3	studies	_	_	NNS	_	_	_	_	_
4	showed	_	_	VBD	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	high-fructose	_	_	JJ	_	_	_	_	_
8	diet	_	_	NN	_	_	_	_	_
9	was	_	_	VBD	_	_	_	_	_
10	associated	_	_	VBN	_	_	_	_	_
11	with	_	_	IN	_	_	_	_	_
12	hypertriglyceridemia	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	hyperinsulinemia	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	impaired	_	_	VBN	_	_	_	_	_
17	glucose	_	_	NN	_	_	_	_	_
18	tolerance	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	insulin	_	_	NN	_	_	_	_	_
21	resistance	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	increased	_	_	VBN	_	_	_	_	_
25	BP	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	body	_	_	NN	_	_	_	_	_
28	weight	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	these	_	_	DT	_	_	_	_	_
4	adverse	_	_	JJ	_	_	_	_	_
5	effects	_	_	NNS	_	_	_	_	_
6	were	_	_	VBD	_	_	_	_	_
7	not	_	_	RB	_	_	_	_	_
8	indicated	_	_	VBN	_	_	_	_	_
9	with	_	_	IN	_	_	_	_	_
10	equivalent	_	_	JJ	_	_	_	_	_
11	calories	_	_	NNS	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	glucose	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	increased	_	_	VBN	_	_	_	_	_
6	fructose	_	_	NN	_	_	_	_	_
7	intake	_	_	NN	_	_	_	_	_
8	for	_	_	IN	_	_	_	_	_
9	0	_	_	CD	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	2	_	_	CD	_	_	_	_	_
12	days	_	_	NNS	_	_	_	_	_
13	evoked	_	_	VBN	_	_	_	_	_
14	increases	_	_	NNS	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	BP	_	_	NN	_	_	_	_	_
17	levels	_	_	NNS	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	high	_	_	JJ	_	_	_	_	_
22	BP	_	_	NN	_	_	_	_	_
23	levels	_	_	NNS	_	_	_	_	_
24	were	_	_	VBD	_	_	_	_	_
25	maintained	_	_	VBN	_	_	_	_	_
26	until	_	_	IN	_	_	_	_	_
27	day	_	_	NN	_	_	_	_	_
28	7	_	_	CD	_	_	_	_	_
29	(	_	_	-LRB-	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	2	_	_	CD	_	_	_	_	_


1	)	_	_	-RRB-	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	great	_	_	JJ	_	_	_	_	_
3	increase	_	_	NN	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	fructose	_	_	NN	_	_	_	_	_
6	consumption	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	last	_	_	JJ	_	_	_	_	_
10	decades	_	_	NNS	_	_	_	_	_
11	leads	_	_	VBZ	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	rapid	_	_	JJ	_	_	_	_	_
15	accumulation	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	triglyceride	_	_	NN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	Occidental	_	_	NNP	_	_	_	_	_
21	population	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_
23	Tran	_	_	NNP	_	_	_	_	_
24	et	_	_	FW	_	_	_	_	_
25	al.	_	_	FW	_	_	_	_	_
26	reported	_	_	VBD	_	_	_	_	_
27	that	_	_	IN	_	_	_	_	_
28	serum	_	_	NN	_	_	_	_	_
29	norepinephrine	_	_	NN	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	triglyceride	_	_	NN	_	_	_	_	_
32	levels	_	_	NNS	_	_	_	_	_
33	are	_	_	VBP	_	_	_	_	_
34	significantly	_	_	RB	_	_	_	_	_
35	increased	_	_	VBN	_	_	_	_	_
36	in	_	_	IN	_	_	_	_	_
37	fructose-fed	_	_	JJ	_	_	_	_	_
38	hypertensive	_	_	JJ	_	_	_	_	_
39	rats	_	_	NNS	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	as	_	_	IN	_	_	_	_	_
42	reflected	_	_	VBN	_	_	_	_	_
43	by	_	_	IN	_	_	_	_	_
44	high	_	_	JJ	_	_	_	_	_
45	SNA	_	_	NN	_	_	_	_	_
46	.	_	_	.	_	_	_	_	_


1	According	_	_	VBG	_	_	_	_	_
2	to	_	_	TO	_	_	_	_	_
3	Tran	_	_	NNP	_	_	_	_	_
4	et	_	_	FW	_	_	_	_	_
5	al.	_	_	FW	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	hypertension	_	_	NN	_	_	_	_	_
8	can	_	_	MD	_	_	_	_	_
9	develop	_	_	VB	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	rats	_	_	NNS	_	_	_	_	_
12	owing	_	_	VBG	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	excessive	_	_	JJ	_	_	_	_	_
15	fructose	_	_	NN	_	_	_	_	_
16	consumption	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	developed	_	_	VBN	_	_	_	_	_
21	hypertension	_	_	NN	_	_	_	_	_
22	can	_	_	MD	_	_	_	_	_
23	be	_	_	VB	_	_	_	_	_
24	treated	_	_	VBN	_	_	_	_	_
25	using	_	_	VBG	_	_	_	_	_
26	a	_	_	DT	_	_	_	_	_
27	sympatholytic	_	_	JJ	_	_	_	_	_
28	agent	_	_	NN	_	_	_	_	_
29	called	_	_	VBN	_	_	_	_	_
30	prazosin	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	which	_	_	WDT	_	_	_	_	_
33	blocks	_	_	VBZ	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	α1-adrenoreceptors	_	_	NNS	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	Hypertension	_	_	NN	_	_	_	_	_
2	inhibition	_	_	NN	_	_	_	_	_
3	by	_	_	IN	_	_	_	_	_
4	prazosin	_	_	NN	_	_	_	_	_
5	did	_	_	VBD	_	_	_	_	_
6	not	_	_	RB	_	_	_	_	_
7	reduce	_	_	VB	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	level	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	triglyceride	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	serum	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	Consistent	_	_	JJ	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	this	_	_	DT	_	_	_	_	_
4	previous	_	_	JJ	_	_	_	_	_
5	result	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	our	_	_	PRP$	_	_	_	_	_
8	data	_	_	NNS	_	_	_	_	_
9	showed	_	_	VBD	_	_	_	_	_
10	that	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	use	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	DGAT1	_	_	NN	_	_	_	_	_
16	inhibitor	_	_	NN	_	_	_	_	_
17	for	_	_	IN	_	_	_	_	_
18	inhibiting	_	_	VBG	_	_	_	_	_
19	serum	_	_	NN	_	_	_	_	_
20	triglyceride	_	_	NN	_	_	_	_	_
21	level	_	_	NN	_	_	_	_	_
22	led	_	_	VBD	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	slight	_	_	JJ	_	_	_	_	_
26	decrease	_	_	NN	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	BP	_	_	NNP	_	_	_	_	_
29	but	_	_	CC	_	_	_	_	_
30	did	_	_	VBD	_	_	_	_	_
31	not	_	_	RB	_	_	_	_	_
32	affect	_	_	VB	_	_	_	_	_
33	SNA	_	_	NNP	_	_	_	_	_
34	(	_	_	-LRB-	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	3	_	_	CD	_	_	_	_	_


1	)	_	_	-RRB-	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	baroreflex	_	_	NN	_	_	_	_	_
3	system	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	an	_	_	DT	_	_	_	_	_
6	important	_	_	JJ	_	_	_	_	_
7	mechanism	_	_	NN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	regulation	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	heart	_	_	NN	_	_	_	_	_
13	rate	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	sympathetic	_	_	JJ	_	_	_	_	_
16	tone	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	consequently	_	_	RB	_	_	_	_	_
20	BP	_	_	NNP	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	Impairment	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	baroreflex	_	_	NN	_	_	_	_	_
4	sensitivity	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	involved	_	_	VBN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	sympathoexcitatory	_	_	JJ	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	sympathoinhibitory	_	_	JJ	_	_	_	_	_
12	effects	_	_	NNS	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	metabolic	_	_	JJ	_	_	_	_	_
15	syndromes	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	previous	_	_	JJ	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	showed	_	_	VBD	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	hypertriglyceridemia	_	_	NN	_	_	_	_	_
7	may	_	_	MD	_	_	_	_	_
8	be	_	_	VB	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	main	_	_	JJ	_	_	_	_	_
11	contributory	_	_	JJ	_	_	_	_	_
12	factor	_	_	NN	_	_	_	_	_
13	associated	_	_	VBN	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	impaired	_	_	VBN	_	_	_	_	_
16	baroreflex	_	_	NN	_	_	_	_	_
17	sensitivity	_	_	NN	_	_	_	_	_
18	during	_	_	IN	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	metabolic	_	_	JJ	_	_	_	_	_
21	syndrome	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_
23	Soncrant	_	_	NNP	_	_	_	_	_
24	et	_	_	FW	_	_	_	_	_
25	al.	_	_	FW	_	_	_	_	_
26	reported	_	_	VBD	_	_	_	_	_
27	that	_	_	IN	_	_	_	_	_
28	elevated	_	_	VBN	_	_	_	_	_
29	BP	_	_	NNP	_	_	_	_	_
30	was	_	_	VBD	_	_	_	_	_
31	increased	_	_	VBN	_	_	_	_	_
32	by	_	_	IN	_	_	_	_	_
33	sympathoexcitation	_	_	NN	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	20	_	_	CD	_	_	_	_	_
36	%	_	_	NN	_	_	_	_	_
37	fructose-induced	_	_	JJ	_	_	_	_	_
38	,	_	_	,	_	_	_	_	_
39	salt-sensitive	_	_	JJ	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	hypertensive	_	_	JJ	_	_	_	_	_
42	rats	_	_	NNS	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	been	_	_	VBN	_	_	_	_	_
4	shown	_	_	VBN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	ingestion	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	fructose	_	_	NN	_	_	_	_	_
10	altered	_	_	VBD	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	secretion	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	hormones	_	_	NNS	_	_	_	_	_
15	that	_	_	WDT	_	_	_	_	_
16	regulate	_	_	VBP	_	_	_	_	_
17	energy	_	_	NN	_	_	_	_	_
18	balance	_	_	NN	_	_	_	_	_
19	associated	_	_	VBN	_	_	_	_	_
20	with	_	_	IN	_	_	_	_	_
21	increased	_	_	VBN	_	_	_	_	_
22	SNA	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	current	_	_	JJ	_	_	_	_	_
6	study	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	although	_	_	IN	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	DGAT1	_	_	NNP	_	_	_	_	_
11	inhibitor	_	_	NN	_	_	_	_	_
12	was	_	_	VBD	_	_	_	_	_
13	administered	_	_	VBN	_	_	_	_	_
14	orally	_	_	RB	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	block	_	_	VB	_	_	_	_	_
17	triglycerides	_	_	NNS	_	_	_	_	_
18	production	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	sympathoexcitation	_	_	NN	_	_	_	_	_
21	was	_	_	VBD	_	_	_	_	_
22	not	_	_	RB	_	_	_	_	_
23	inhibited	_	_	VBN	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	fructose-fed	_	_	JJ	_	_	_	_	_
26	rats	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Dos	_	_	NNP	_	_	_	_	_
2	Santos	_	_	NNP	_	_	_	_	_
3	et	_	_	NNP	_	_	_	_	_
4	al	_	_	NNP	_	_	_	_	_
5	indicated	_	_	VBD	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	fructose	_	_	NN	_	_	_	_	_
8	consumption	_	_	NN	_	_	_	_	_
9	similarly	_	_	RB	_	_	_	_	_
10	reduced	_	_	VBD	_	_	_	_	_
11	both	_	_	CC	_	_	_	_	_
12	baroreflex	_	_	NN	_	_	_	_	_
13	sensitivity	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	activity	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Our	_	_	PRP$	_	_	_	_	_
2	research	_	_	NN	_	_	_	_	_
3	further	_	_	RBR	_	_	_	_	_
4	indicated	_	_	VBD	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	fructose	_	_	NN	_	_	_	_	_
7	intake	_	_	NN	_	_	_	_	_
8	may	_	_	MD	_	_	_	_	_
9	reduce	_	_	VB	_	_	_	_	_
10	NO	_	_	DT	_	_	_	_	_
11	levels	_	_	NNS	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	NTS	_	_	NNP	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	cause	_	_	VB	_	_	_	_	_
17	baroreflex	_	_	NN	_	_	_	_	_
18	dysfunction	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	which	_	_	WDT	_	_	_	_	_
21	further	_	_	RB	_	_	_	_	_
22	stimulates	_	_	VBZ	_	_	_	_	_
23	SNA	_	_	NNP	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	induces	_	_	VBZ	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	development	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	high	_	_	JJ	_	_	_	_	_
30	BP	_	_	NN	_	_	_	_	_
31	(	_	_	-LRB-	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	4	_	_	CD	_	_	_	_	_


1	and	_	_	CC	_	_	_	_	_


1	Figure	_	_	NN	_	_	_	_	_
2	5	_	_	CD	_	_	_	_	_


1	)	_	_	-RRB-	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Generally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	anesthetics	_	_	NNS	_	_	_	_	_
4	affect	_	_	VBP	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	basal	_	_	JJ	_	_	_	_	_
7	levels	_	_	NNS	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	sympathetic	_	_	JJ	_	_	_	_	_
10	nerve	_	_	NN	_	_	_	_	_
11	activity	_	_	NN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	regulate	_	_	VB	_	_	_	_	_
14	blood	_	_	NN	_	_	_	_	_
15	pressure	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	which	_	_	WDT	_	_	_	_	_
18	plays	_	_	VBZ	_	_	_	_	_
19	an	_	_	DT	_	_	_	_	_
20	important	_	_	JJ	_	_	_	_	_
21	role	_	_	NN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	controlling	_	_	VBG	_	_	_	_	_
24	cardiovascular	_	_	JJ	_	_	_	_	_
25	function	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_
27	Sun	_	_	NNP	_	_	_	_	_
28	et	_	_	FW	_	_	_	_	_
29	al.	_	_	FW	_	_	_	_	_
30	indicated	_	_	VBD	_	_	_	_	_
31	that	_	_	IN	_	_	_	_	_
32	anesthesia	_	_	NN	_	_	_	_	_
33	attenuated	_	_	VBD	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	excitatory	_	_	JJ	_	_	_	_	_
36	response	_	_	NN	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	RSNA	_	_	NNP	_	_	_	_	_
39	and	_	_	CC	_	_	_	_	_
40	HR	_	_	NN	_	_	_	_	_
41	to	_	_	TO	_	_	_	_	_
42	anaphylactic	_	_	JJ	_	_	_	_	_
43	hypotension	_	_	NN	_	_	_	_	_
44	,	_	_	,	_	_	_	_	_
45	while	_	_	IN	_	_	_	_	_
46	these	_	_	DT	_	_	_	_	_
47	excitatory	_	_	JJ	_	_	_	_	_
48	responses	_	_	NNS	_	_	_	_	_
49	were	_	_	VBD	_	_	_	_	_
50	attenuated	_	_	VBN	_	_	_	_	_
51	by	_	_	IN	_	_	_	_	_
52	anesthetics	_	_	NNS	_	_	_	_	_
53	in	_	_	IN	_	_	_	_	_
54	the	_	_	DT	_	_	_	_	_
55	order	_	_	NN	_	_	_	_	_
56	ketamine-xylazine	_	_	NN	_	_	_	_	_
57	>	_	_	SYM	_	_	_	_	_
58	urethane	_	_	NN	_	_	_	_	_
59	=	_	_	SYM	_	_	_	_	_
60	pentobarbital	_	_	NN	_	_	_	_	_
61	.	_	_	.	_	_	_	_	_
62	Bencze	_	_	NNP	_	_	_	_	_
63	et	_	_	FW	_	_	_	_	_
64	al.	_	_	FW	_	_	_	_	_
65	found	_	_	VBD	_	_	_	_	_
66	that	_	_	IN	_	_	_	_	_
67	pentobarbital	_	_	JJ	_	_	_	_	_
68	anesthesia	_	_	NN	_	_	_	_	_
69	had	_	_	VBD	_	_	_	_	_
70	a	_	_	DT	_	_	_	_	_
71	modest	_	_	JJ	_	_	_	_	_
72	influence	_	_	NN	_	_	_	_	_
73	on	_	_	IN	_	_	_	_	_
74	the	_	_	DT	_	_	_	_	_
75	BP	_	_	NN	_	_	_	_	_
76	level	_	_	NN	_	_	_	_	_
77	and	_	_	CC	_	_	_	_	_
78	its	_	_	PRP$	_	_	_	_	_
79	maintenance	_	_	NN	_	_	_	_	_
80	by	_	_	IN	_	_	_	_	_
81	the	_	_	DT	_	_	_	_	_
82	above	_	_	JJ	_	_	_	_	_
83	vasoactive	_	_	JJ	_	_	_	_	_
84	systems	_	_	NNS	_	_	_	_	_
85	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	anesthetics	_	_	NNS	_	_	_	_	_
5	may	_	_	MD	_	_	_	_	_
6	inhibit	_	_	VB	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	primary	_	_	JJ	_	_	_	_	_
9	area	_	_	NN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	baroreceptor	_	_	NN	_	_	_	_	_
13	reflex	_	_	NN	_	_	_	_	_
14	pathway	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	central	_	_	JJ	_	_	_	_	_
18	nervous	_	_	JJ	_	_	_	_	_
19	system	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	resulting	_	_	VBG	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	attenuation	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	baroreceptor	_	_	NN	_	_	_	_	_
27	reflex	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	Therefore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	sympathetic	_	_	JJ	_	_	_	_	_
4	nerve	_	_	NN	_	_	_	_	_
5	activity	_	_	NN	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	cardiovascular	_	_	JJ	_	_	_	_	_
8	function	_	_	NN	_	_	_	_	_
9	may	_	_	MD	_	_	_	_	_
10	be	_	_	VB	_	_	_	_	_
11	affected	_	_	VBN	_	_	_	_	_
12	by	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	anesthetic	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	there	_	_	EX	_	_	_	_	_
4	were	_	_	VBD	_	_	_	_	_
5	some	_	_	DT	_	_	_	_	_
6	limitations	_	_	NNS	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	our	_	_	PRP$	_	_	_	_	_
9	study	_	_	NN	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	First	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	measured	_	_	VBD	_	_	_	_	_
5	BP	_	_	NNP	_	_	_	_	_
6	during	_	_	IN	_	_	_	_	_
7	consciousness	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	whereas	_	_	IN	_	_	_	_	_
10	RSNA	_	_	NNP	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	baroreflex	_	_	NN	_	_	_	_	_
13	sensitivity	_	_	NN	_	_	_	_	_
14	measurements	_	_	NNS	_	_	_	_	_
15	were	_	_	VBD	_	_	_	_	_
16	performed	_	_	VBN	_	_	_	_	_
17	under	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	anesthetic	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Second	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	our	_	_	PRP$	_	_	_	_	_
4	sample	_	_	NN	_	_	_	_	_
5	size	_	_	NN	_	_	_	_	_
6	was	_	_	VBD	_	_	_	_	_
7	relatively	_	_	RB	_	_	_	_	_
8	small	_	_	JJ	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	study	_	_	NN	_	_	_	_	_
12	used	_	_	VBD	_	_	_	_	_
13	nonparametric	_	_	JJ	_	_	_	_	_
14	methods	_	_	NNS	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	analysis	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Third	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	fructose	_	_	NN	_	_	_	_	_
5	group	_	_	NN	_	_	_	_	_
6	was	_	_	VBD	_	_	_	_	_
7	used	_	_	VBN	_	_	_	_	_
8	as	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	control	_	_	NN	_	_	_	_	_
11	group	_	_	NN	_	_	_	_	_
12	only	_	_	RB	_	_	_	_	_
13	on	_	_	IN	_	_	_	_	_
14	day	_	_	NN	_	_	_	_	_
15	0	_	_	CD	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_

